Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells

Life Sciences

Volumn 77, Issue 25, 2005, Pages 3231-3241

  Takenaka, Katsuhiko ^a   Yamagishi, Sho Ichi ^a   Jinnouchi, Yuko ^a   Nakamura, Kazuo ^a   Matsui, Takanori ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Apoptosis; Osteosarcoma; PEDF; VEGF

Indexed keywords

CASPASE 3; CASPASE 7; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR CELL;

APOPTOSIS; CASPASE 3; CASPASE 7; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE PROTEINS; GENE EXPRESSION; HUMANS; NERVE GROWTH FACTORS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MAMMALIA; MUS MUSCULUS;

EID: 26444583306     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.048     Document Type: Article

References (31)

1. R. Abe, T. Shimizu, S. Yamagishi, A. Shibaki, S. Amano, Y. Inagaki, H. Watanabe, H. Sugawara, H. Nakamura, M. Takeuchi, T. Imaizumi, and H. Shimizu Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo American Journal of Pathology 164 4 2004 1225 1232
2. C. Bacakova, V. Stary, O. Kofronova, and V. Lisa Polishing and coating carbon fiber-reinforced carbon composites with a carbon-titanium layer enhances adhesion and growth of oseteoblast-like MG63 cells and vascular smooth muscle cells in vitro Journal of Biomedical Materials Research 54 4 2001 567 578
3. G. Bacci, S. Ferrari, N. Delepine, F. Bertoni, P. Picci, M. Mercuri, P. Bacchini, A. Brach del Prever, A. Tienghi, A. Comandone, and M. Campanacci Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin Journal of Clinical Oncology 16 2 1998 658 663
4. G.M. Cohen Caspases: the executioners of apoptosis Biochemical Journal 326 Pt 1 1997 1 16
5. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H.J. Xu, W. Benedict, and N.P. Bouck Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 4525 1999 245 248
6. E.J. Duh, H.S. Yang, I. Suzuma, M. Miyagi, E. Youngman, K. Mori, M. Katai, L. Yan, K. Suzuma, K. West, S. Davarya, P. Tong, P. Gehlbach, J. Pearlman, J.W. Crabb, L.P. Aiello, P.A. Campochiaro, and D.J. Zack Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth Investigative Ophthalmology and Visual Science 43 3 2002 821 829
7. I.J. Fidler, and L.M. Ellis The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 79 2 1994 185 188
8. J. Folkman Angiogenesis: initiation and control Annals of New York Academy of Science 401 1982 212 227
9. J. Folkman Role of angiogenesis in tumor growth and metastasis Seminars in Oncology 29 6 Suppl 16 2002 15 18
10. J.L. Grem, S.A. King, R.E. Wittes, and B. Leyland-Jones The role of methotrexate in osteosarcoma Journal of the National Cancer Institute 80 9 1998 626 655
11. H. Hirata, A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada Caspases are activated in a branched protease cascade and control distinct downstream process in Fas-induced apoptosis Journal of Experimental Medicine 187 4 1998 587 600
12. M. Kaya, T. Wada, T. Akatsuka, S. Kawaguchi, S. Nagoya, M. Shindoh, F. Higashino, F. Mezawa, F. Okada, and S. Ishii Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis Clinical Cancer Research 6 2 2000 572 577
13. K.J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H.S. Phillips, and N. Ferrara Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 6423 1993 841 844
14. K. Matsumoto, H. Ishikawa, D. Nishimura, K. Hamasaki, K. Nakao, and K. Eguchi Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma Hepatology 40 1 2004 252 259
15. J. Mordoh, R.D. Chacon, and J. Filmus Isolation of tumor cells from patients with oseosarcoma and analysis of their sensitivity to methotrexate Cancer Research 41 9 Pt 1 1981 3621 3628
16. M. Nomura, S. Yamagishi, S. Harada, Y. Hayashi, T. Yamashita, J. Yamashita, and H. Yamamoto Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes Journal of Biological Chemistry 270 47 1995 28316 28324
17. S.V. Petersen, Z. Valnickova, and J.J. Enghild Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization Biochemical Journal 374 Pt 1 2003 199 206
18. R.A. Schwartzman, and J.A. Cidlowski Apoptosis: the biochemistry and molecular biology of programmed cell death Endocrine Reviews 14 2 1993 133 151
19. D.W. Siemann, D.J. Chaplin, and M.R. Horsman Vascular-targeting therapies for treatment of malignant disease Cancer 100 12 2004 2491 2499
20. J. Spranger, M. Osterhoff, M. Reimann, M. Mohlig, M. Ristow, M.K. Francis, V. Cristofalo, H.P. Hammes, G. Smith, M. Boulton, and A.F. Pfeiffer Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease Diabetes 50 12 2001 2641 26415
21. J. Tombran-Tink, C.G. Chader, and L.V. Johnson PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity Experimental Eye Research 53 3 1991 411 414
22. O.V. Volpert, T. Zaichuk, W. Zhou, F. Reiher, T.A. Ferguson, P.M. Stuart, M. Amin, and N.P. Bouck Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor Nature Medicine 8 4 2002 349 357
23. S. Yamagishi, H. Yonekura, Y. Yamamoto, K. Katsuno, F. Sato, I. Mita, H. Ooka, N. Satozawa, T. Kawakami, M. Nomura, and H. Yamamoto Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor Journal of Biological Chemistry 272 13 1997 8723 8730
24. S. Yamagishi, H. Fujimori, H. Yonekura, Y. Yamamoto, and H. Yamamoto Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells Diabetologia 41 12 1998 1435 1441
25. S. Yamagishi, Y. Inagaki, S. Amano, T. Okamoto, and M. Takeuchi Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes International Journal on Tissue Reactions 24 4 2002 137 142
26. S. Yamagishi, Y. Inagaki, S. Amano, T. Okamoto, M. Takeuchi, and Z. Makita Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochemical and Biophysical Research Communications 296 4 2002 877 882
27. S. Yamagishi, Y. Inagaki, T. Okamoto, S. Amano, K. Koga, M. Takeuchi, and Z. Makita Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells Journal of Biological Chemistry 277 23 2002 20309 20315
28. S. Yamagishi, S. Amano, Y. Inagaki, T. Okamoto, K. Koga, N. Sasaki, H. Yamotomo, M. Takeuchi, and Z. Makita Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes Biochemical and Biophysical Research Communications 290 3 2002 973 978
29. S. Yamagishi, S. Amano, Y. Inagaki, T. Okamoto, M. Takeuchi, and H. Inoue Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties Microvascular Research 65 3 2003 186 190
30. S. Yamagishi, Y. Inagaki, T. Okamoto, S. Amano, K. Koga, and M. Takeuchi Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells Kidney International 63 2 2003 464 473
31. S. Yamagishi, Y. Inagaki, K. Nakamura, R. Abe, T. Shimizu, A. Yoshimura, and T. Imaizumi Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation Journal of Molecular and Cellular Cardiology 37 2 2004 497 506